SCA
ONC

Snowden Capital Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Snowden Capital Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$355K Buy
1,197
+255
+27% +$82.5K 0.01% 950
2025
Q4 		$286K Sell
942
-49
-5% -$16K 0.01% 1065
2025
Q3 		$338K Buy
991
+68
+7% +$20.6K 0.01% 968
2025
Q2 		$223K Buy
923
+27
+3% +$6.62K 0.01% 1134
2025
Q1 		$244K Buy
+896
New +$209K 0.01% 1073
2024
Q4 		– Sell
-961
Closed -$216K – 1272
2024
Q3 		$216K Buy
+961
New +$173K 0.01% 1142

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Snowden Capital Advisors's ONC Position: Q1 2026 in Review

Snowden Capital Advisors increased its BeOne Medicines Ltd (ONC) stake by 27% in Q1 2026, buying an estimated $82.5K and bringing the position to 1,197 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #950.

Snowden Capital Advisors first reported a position in ONC in Q3 2024 and has held it in 6 quarters since. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Snowden Capital Advisors held 1,197 shares of BeOne Medicines Ltd worth $355K as of Q1 2026.
  • Snowden Capital Advisors bought 255 BeOne Medicines Ltd shares in Q1 2026, an estimated $82.5K.
  • BeOne Medicines Ltd made up 0.01% of Snowden Capital Advisors's portfolio in Q1 2026, its #950 holding.
  • Snowden Capital Advisors first reported a position in BeOne Medicines Ltd in Q3 2024 and has held it in 6 quarters since.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.